Ignite Creation Date:
2024-05-06 @ 8:26 AM
Last Modification Date:
2024-10-26 @ 12:00 PM
Study NCT ID:
NCT02736448
Status:
UNKNOWN
Last Update Posted:
2021-02-26
First Post:
2016-04-07
Brief Title:
177Lutethium - Peptide Receptor Radionuclide Therapy Lu-PRRT Plus Capecitabine Versus Lu-PRRT in FDG Positive Gastro-entero-pancreatic Neuroendocrine Tumors
Sponsor:
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Organization:
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Organization Data
Organization:
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Class:
OTHER
Study ID:
IRST10017
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None